II
COLL icon

Inspire Investing’s Collegium Pharmaceutical COLL Stock Holding History

Inspire Investing’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.72K Hold
113
– – ﹤0.01% 984
2025
Q4 		$5.21K Buy
+113
New +$4.73K ﹤0.01% 953
2024
Q4 		– Sell
-8,813
Closed -$341K – 831
2024
Q3 		$341K Sell
8,813
-15,985
-64% -$570K 0.03% 756
2024
Q2 		$798K Buy
24,798
+2,917
+13% +$101K 0.09% 242
2024
Q1 		$849K Sell
21,881
-3,486
-14% -$122K 0.09% 264
2023
Q4 		$781K Sell
25,367
-2,473
-9% -$61.9K 0.09% 251
2023
Q3 		$622K Buy
27,840
+873
+3% +$19.9K 0.08% 258
2023
Q2 		$580K Buy
+26,967
New +$612K 0.07% 265

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return